Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

This study has been completed.
Sponsor:
Collaborators:
Sanofi
Roche Pharma AG
Information provided by (Responsible Party):
Spanish Cooperative Group for Gastrointestinal Tumour Therapy
ClinicalTrials.gov Identifier:
NCT00335595
First received: June 9, 2006
Last updated: February 19, 2013
Last verified: February 2013